Some companies can certainly justify their frothy valuations, and a bunch certainly don't. Many of these companies need the capital infusions to stay afloat, an

Some companies can certainly justify their frothy valuations, and a bunch certainly don't. Many of these companies need the capital infusions to stay afloat, and I can see a bunch folding as capital market risk tolerances start to contract.